Literature DB >> 19633365

Genetic classification of oral and oropharyngeal carcinomas identifies subgroups with a different prognosis.

Serge J Smeets1, Ruud H Brakenhoff, Bauke Ylstra, Wessel N van Wieringen, Mark A van de Wiel, C René Leemans, Boudewijn J M Braakhuis.   

Abstract

The common risk factors for oral and oropharyngeal cancer are tobacco smoking and alcohol consumption, and recently the human papillomavirus (HPV) was shown to be involved in a subgroup. HPV-positive and -negative carcinomas can be distinguished on basis of their genetic profiles. Aim of this study was to investigate patterns of chromosomal aberrations of HPV-negative oral and oropharyngeal squamous cell carcinomas (OOSCC) in order to improve stratification of patients regarding outcome. Thirty-nine OOSCCs were classified on basis of their genetic pattern determined by array comparative genomic hybridization (aCGH). Resulting groups were related to patient and tumor characteristics using the Fisher's exact test and in addition to survival with the Kaplan-Meier and log rank tests. Classification distinguished three groups, one characterized by hardly any chromosomal aberration (N=8) and another by a relatively high level (N=26), and one with a very high level (N=5) of chromosomal aberrations. This classification was significantly (p=0.003) associated with survival, with the best survival in the genetically 'silent' group and the worst survival in the most aberrant group. The silent profile was significantly (p<0.05) associated with wild-type TP53, an absence of alcohol consumption and a female gender. These carcinomas were negative for microsatellite instability. This classification of OOSCC was confirmed in an independent set of 89 oral carcinomas. In conclusion, the discovery of these new classes of oral and oropharyngeal cancer with unique genetic and clinical characteristics has important consequences for future basic and clinical studies.

Entities:  

Mesh:

Year:  2009        PMID: 19633365      PMCID: PMC4618915          DOI: 10.3233/CLO-2009-0471

Source DB:  PubMed          Journal:  Cell Oncol        ISSN: 1570-5870            Impact factor:   6.730


  26 in total

1.  Quantitative diffusion-weighted MRI parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.

Authors:  C S Schouten; P de Graaf; E Bloemena; B I Witte; B J M Braakhuis; R H Brakenhoff; C R Leemans; J A Castelijns; R de Bree
Journal:  AJNR Am J Neuroradiol       Date:  2015-02-26       Impact factor: 3.825

2.  Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis.

Authors:  Aditi Bhattacharya; Ritu Roy; Antoine M Snijders; Gregory Hamilton; Jesse Paquette; Taku Tokuyasu; Henrik Bengtsson; Richard C K Jordan; Adam B Olshen; Daniel Pinkel; Brian L Schmidt; Donna G Albertson
Journal:  Clin Cancer Res       Date:  2011-11-08       Impact factor: 12.531

3.  HPV induction of APOBEC3 enzymes mediate overall survival and response to cisplatin in head and neck cancer.

Authors:  Kayla L Conner; Asra N Shaik; Elmira Ekinci; Seongho Kim; Julie J Ruterbusch; Michele L Cote; Steve M Patrick
Journal:  DNA Repair (Amst)       Date:  2020-01-16

Review 4.  Current potential and limitations of molecular diagnostic methods in head and neck cancer.

Authors:  Magdy E Mahfouz; Juan P Rodrigo; Robert P Takes; Mohamed N Elsheikh; Alessandra Rinaldo; Ruud H Brakenhoff; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06       Impact factor: 2.503

5.  Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis.

Authors:  Darawalee Wangsa; Salim Akhter Chowdhury; Michael Ryott; E Michael Gertz; Göran Elmberger; Gert Auer; Elisabeth Åvall Lundqvist; Stefan Küffer; Philipp Ströbel; Alejandro A Schäffer; Russell Schwartz; Eva Munck-Wikland; Thomas Ried; Kerstin Heselmeyer-Haddad
Journal:  Int J Cancer       Date:  2015-08-28       Impact factor: 7.396

Review 6.  The molecular biology of head and neck cancer.

Authors:  C René Leemans; Boudewijn J M Braakhuis; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2010-12-16       Impact factor: 60.716

Review 7.  Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.

Authors:  M Giefing; M Wierzbicka; K Szyfter; J C Brenner; B J Braakhuis; R H Brakenhoff; C R Bradford; J A Sorensen; A Rinaldo; J P Rodrigo; R P Takes; A Ferlito
Journal:  Eur J Cancer       Date:  2016-02-04       Impact factor: 9.162

Review 8.  The molecular pathogenesis of head and neck squamous cell carcinoma.

Authors:  S Michael Rothenberg; Leif W Ellisen
Journal:  J Clin Invest       Date:  2012-06       Impact factor: 14.808

Review 9.  Unraveling cancer lineage drivers in squamous cell carcinomas.

Authors:  Yinglu Guan; Guan Wang; Danielle Fails; Priyadharsini Nagarajan; Yejing Ge
Journal:  Pharmacol Ther       Date:  2019-12-11       Impact factor: 12.310

10.  Possibility of the use of public microarray database for identifying significant genes associated with oral squamous cell carcinoma.

Authors:  Ki-Yeol Kim; In-Ho Cha
Journal:  Genomics Inform       Date:  2012-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.